Hanmi Pharmaceutical
Update in progress008930.KS (KSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Distribution
Hanmi Science Co., Ltd. develops, manufactures, and sells pharmaceutical products in Korea and abroad. It focuses on diabetes and cancer drugs, bowel preparation and cold medicines for children and adults, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment, plus automated drug management systems. Products are sold through online and offline pharmacies. Founded in 1973 and headquartered in Seoul, it was renamed in 2012 from Hanmi Holdings.
Company score
- Sentiment
- 0.43
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.32
- Governance
- 0.20
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.14
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.28
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!